T he term "critically ill polyneuropathy' was first used to describe a syndrome of severe weakness with reduced or absent limb reflexes together with reduced compound motor action potentials and sensory action potentials in the setting of sepsis and multiple organ failure (1) . It is now recognized that in long-stay intensive care patients, critical illness polyneuropathy (CIP), as the condition is now known, is common, with a prevalence of between 58% and 96%, depending on the criteria used for inclusion and diagnosis (2, 3) . Risk factors include sepsis, duration of intensive care unit (ICU) stay (4) , and the development of the multiple organ dysfunction syndrome (5) . Some studies have implicated muscle relaxants and corticosteroids in the pathogenesis of neuromuscular weakness in intensive care patients (6, 7) . In individual cases, weakness may be a result of muscle wasting, myopathy, neuropathy, or a combination of these, but the relative frequency of these conditions is unclear (8 -12) .
There are few systematic studies of the long-term neurologic sequelae of critical illness polyneuropathies and myopathies, and most published reports have involved only relatively small numbers of patients followed up for relatively short periods of time (13) (14) (15) (16) (17) (18) (19) (20) (21) . Although in one study single-fiber electromyography was used to measure "jitter" on the ICU (22) , there is no information on the use of this technique to assess patients after discharge from intensive care. Most follow-up studies of unselected groups of ICU survivors have concentrated on quality of life and functional outcome, usually assessed by postal questionnaire, rather than the neurologic and neurophysiologic sequelae of critical illness (23, 24) . We therefore set out to establish the prevalence, clinical characteristics, and electrophysiologic features of residual neuromuscular dysfunction after protracted critical illness using clinical assessment, neurologic examination, and neurophysiologic investigation.
MATERIALS AND METHODS
The study was approved by the local ethics committees. The ICU databases from a university hospital and two District General Hospitals were searched to identify all patients with an ICU stay of Ն28 days between January 1, 1993, and December 31, 1997. After consult-Objective: To establish the prevalence, clinical characteristics, and electrophysiologic features of residual neuromuscular dysfunction after prolonged critical illness.
Design: Prospective follow-up study of survivors of prolonged critical illness.
Setting: A university hospital and two district general hospitals in the UK.
Patients: The study occurred for a period of 5 yrs. All patients during that time who were in the intensive care unit for >28 days were entered in the study.
Measurements and Main Results: At follow-up, length of intensive care unit and hospital stay, duration of mechanical ventilation and admission Acute Physiology and Chronic Health Evaluation II score were recorded from the case notes. A clinical history was obtained, a Barthel Index disability score was calculated, and a full neurologic examination was performed. Nerve conduction studies, needle electromyography, single-fiber electromyography and thermal thresholds were performed. A total of 195 patients were identified. There were 86 survivors, of whom 47 could be contacted and 22 consented to be studied. The median time from intensive care unit discharge to follow-up was 43 months (range, 12-57 months). All gave a clear history of severe weakness and functional impairment after hospital discharge and, in all, recovery was prolonged. Motor or sensory deficits were present on clinical examination in 59% of the patients studied. (25) . The total doses of any muscle relaxants and corticosteroids administered during the ICU admission were recorded. Details of any neurophysiologic investigations or muscle biopsies performed during their ICU admission were recorded.
When the patients returned, informed written consent was obtained and a clinical history was taken, with particular reference to any conditions likely to cause neuromuscular disease or immobility. A full examination was performed, including detailed evaluation of any sensory deficits; muscle power was graded according to the MRC scale. Weakness was defined as MRC grade 4 or less (26) . The Barthel Index was calculated for each patient (27) .
Nerve conduction studies were performed by an experienced neurophysiologist (I. R. Ghosh or V. P. Misra) using a Medelec MS92 (Oxford Instruments, Surrey, UK) and standard recording techniques. Sensory action potentials were recorded from the median, ulnar, radial, and sural nerves. Motor studies were performed in the median, ulnar, common peroneal, and posterior tibial nerves. Action potential amplitudes were measured from base to peak in motor studies and peak to peak in sensory studies. Limbs were warmed with heat packs if skin temperature was Ͻ33°C. Repetitive stimulation (3 Hz) of the distal ulnar nerve was performed before and after 30 secs of maximum sustained voluntary contraction of the abductor digiti minimi. Electromyography, using the MS92, was performed using a coaxial needle electrode in tibialis anterior, vastus medialis, extensor digitorum communis, and deltoid muscles. Three insertions were performed in each of these muscles; resting and voluntarily activated potentials were analyzed.
Single-fiber electromyography, using a Dantec machine (Medtronic inc, Minneapolis, MN) and standard techniques, was performed in tibialis anterior and extensor digitorum communis muscles by using a single-fiber needle electrode. Mean consecutive differences and fiber density values were calculated. Thermal threshold studies (Marstock method) for warming and cooling were performed in the palm of the hand and sole of the foot by using the Somedic system (Somedic MSA, Harby, Sweden) with a rate of change of temperature of 1°C per second. AAEM tables of age-related normative values were used to compare mean consecutive differences and fiber densities (28) , and local departmental normative values were used to compare thermal thresholds.
The SPSS for Windows 6.0 (1993) statistical package was used (SPSS, Chicago, IL). The Mann-Whitney U test was used to determine whether there was an association between age or time from ICU discharge to follow-up and presence of fibrillations and positive neurologic findings. A p value of Ͻ.05 was considered to be significant.
RESULTS
A total of 195 patients with an ICU stay of Ն28 days were identified, of whom 86 (42%) were still alive. Of these, 22 lived Ͼ20 miles from the hospital and 17 were not able to be contacted. The remaining 47 patients were contacted, of whom 25 declined to return: five for reasons of ill health or immobility. Twenty-two patients were studied (Fig. 1) .
The median (range) age of the study group of 22 patients was 62 yrs (45-78 yrs). The median time from ICU discharge to follow-up was 42.5 months (12-57 months). The median APACHE score was 23.5 (11-32). All patients had episodes of sepsis during their stay and at least two organ failures (median, 3 [2] [3] [4] [5] ) while in the ICU. The median ICU stay was 40.5 days (30 -104 days), median duration of mechanical ventilation was 37 days (7-104 days), and the median hospital stay was 82 days (42-376 days) ( Table  1) . The median age, APACHE II score, ICU stay, and hospital stay of recruited patients were similar to those of the whole survivor group (n ϭ 86), which were 60 yrs, 21, 34, and 69 days, respectively. Eleven patients received no muscle relaxants, and a further six received these agents for Ͻ24 hrs. Only one patient received vecuronium, seven received corticosteroids, and five patients received both.
One patient had a head injury; none were diabetic. Patient 11 was in end-stage renal failure before ICU admission and continued to receive regular hemodialysis. Patients 7, 8, and 10 complained of cervical and lumbar pain, which had not been investigated further. Three patients had an electromyographic (EMG) investigation during their ICU admission. One was normal (patient 7 (8) .
At follow-up, all patients gave a clear history of extreme weakness after ICU and hospital discharge. The Barthel Index at follow-up is shown in Table 1 . Neurologic examination at follow-up revealed sensory deficits in six of the subjects (27%), motor weakness in four patients (18%), and both sensory and motor deficits in three patients (14%). Patients 8 and 19 had bilateral peroneal nerve palsies with foot drop and absent ankle jerk reflexes dating from their ICU stay. Three other patients had bilateral upper limb weakness (patients 3, 10, and 11). No patient had any documented weakness or sensory deficits before ICU admission.
In all patients, nerve conduction velocities were normal. Sural nerve sensory action potentials were absent in five patients. Compound motor action potentials were reduced in one or both peroneal nerves in five patients and in the tibial nerve in three patients. Repetitive stimulation did not show an abnormal decremental response in any of the patients. Fibrillations were detected in the tibialis anterior muscle in eight of the patients (36%) but were uncommon (Ͻ10%) in the other muscle groups. Twenty-one patients (95%) had EMG findings of chronic partial denervation (high firing rates, long duration polyphasic motor unit potentials) in tibialis an- terior and extensor digitorum communis. There was a slightly lower prevalence of this abnormality in the vastus medialis, 18 (81%), and deltoid, 13 (59%).
The two patients (patients 2 and 3) in whom a diagnosis of CIP was made during their ICU admission had persistent weakness, and EMG evidence of denervation was seen in all muscle groups. Furthermore, patient 3, who had severe CIP, had fibrillations in all muscle groups 42 months after ICU discharge. Patient 5, who had a necrotizing myopathy, had no persisting weakness and, significantly, was the only patient in the study in whom there was no evidence of denervation.
A total of 21 patients had jitter evaluated by single-fiber electromyography; in ten patients, the fiber density was calculated. Jitter was normal in all patients in the extensor digitorum communis and was increased in only two patients (who had peroneal nerve palsy) in the tibialis anterior. There was increased fiber density in one patient in the extensor digitorum communis and in seven patients in the tibialis anterior. On thermal threshold testing, four patients had abnormal responses to warming and two had an abnormal response to cooling in the lower limb. There were no significant associations between either age or time from ICU discharge to follow-up and presence of fibrillations or positive neurologic findings.
DISCUSSION
This follow-up study demonstrates that persisting weakness and residual clinical motor and sensory neurologic deficits are extremely common in longterm survivors of protracted critical illness (Ͼ4 wks in the ICU). All patients gave a clear history of a prolonged recovery period after hospital discharge, associated with significant weakness, fatigue, and difficulty with mobilization. In some patients, this weakness was still clinically evident up to 4 yrs after ICU discharge and, in one patient, was severe. Neurophysiologic evidence of chronic partial denervation, consistent with previous CIP or a purely motor neuropathy, was almost invariable and could be found up to 5 yrs after ICU discharge in Ͼ90% of these long-stay patients. This denervation probably explains the extreme weakness suffered by such patients, although in most cases, weakness will be exacerbated by muscle wasting due to catabolism and, in some, by myopathic changes. Signs of weakness and denervation were more frequent in the distal muscles of the lower limbs, and two patients had a bilateral common peroneal nerve palsy, a complication previously reported in survivors of intensive care (17) . Despite the persisting neurologic symptoms and signs, however, few of the study patients had serious disability, as determined by the Barthel Index, perhaps because this evaluation was determined on only one occasion at a median interval of 43 months (12-57 months) after ICU discharge.
Median age, APACHE II score, sex ratio, and length of ICU stay in the study group of patients (n ϭ 22) were comparable with those of the whole group of survivors and the total sample population (n ϭ 195). It is possible, however, that there was some degree of selection bias in that patients who were unable to return may have been more severely disabled; the severity of neuromuscular dysfunction in long-term survivors may therefore have been underestimated. It is also possible that neuromuscular disorders that 1  75  48  4  24  29  37  48  85  -at 1,000  CABG  2  62  24  3  13  36  42  42 T  100  --Trauma  3  45  42  4  24  59  65  114 T  100  -at 67,500  Trauma  4  61  22  3  32  N/A  32  44  100  --Respiratory failure  5  62  38  3  23  31  32  61  95  --CABG  6  71  57  5  16  32  36  43  100  --CABG  7  74  47  5  31  21  38  77  95  --TURP  8  62  44  4  23  59  61  77  95  -at 23,820  CABG  9  61  27  2  11  7  34  376  100  hc 1.5 g  at 12,870  CABG  10  66  46  3  25  38  39  95  100  --Pancreatitis  11  50  43  5  23  26  30  71 ICU, intensive care unit; APACHE II, Acute Physiology and Chronic Health Evaluation II; NMBA, neuromuscular blocking agent; CABG, coronary artery bypass graft; N/A, not applicable; T, transfer; TURP, transurethral prostatectomy; at, atracurium; hc, hydrocortisone; pred, prednisone; mpred, methylprednisolone. predated ICU admission, or which developed de novo after ICU discharge, could have accounted for some of our findings. However, the patients all related the development of weakness to their time in intensive care, and none had any known illnesses that could have explained the neurologic findings. In particular, none of the patients were diabetic.
Previous studies have indicated that when CIP is mild or moderate, recovery is relatively rapid and complete, whereas in those with more severe polyneuropathy, recovery is limited and mortality is high (19, 20) . Jarrett and Mogelof (16) noted severe disability in patients with CIP presenting for rehabilitation up to 4.5 months after critical illness that responded to aggressive rehabilitation. In another study, severe residual handicap was found in 22% of all 1-yr survivors with CIP, whereas a control group of patients who had not developed CIP had no residual handicap at this time (2) . The longer-term prognosis for CIP survivors ranges from complete recovery over a period of several months with resolution of neurophysiologic signs to persisting weakness with evidence of denervation up to 3 yrs after ICU discharge (15, 16, 17) . More recently, Zifko (21) reported that 11 of 13 patients with CIP had clinical manifestations 13-24 months after diagnosis, whereas in our study, clinical weakness was still present in some patients up to 4 yrs after discharge from ICU. Another recent study of 19 ICU survivors, examined 2 yrs after admission to a rehabilitation unit with severe CIP, found that although many had recovered completely within a few months to a year, some severe deficits, including quadriplegia and paraparesis, persisted and a few died while undergoing rehabilitation (18) .
In the patients reported here, who were selected solely on the basis of a prolonged stay in the ICU, the EMG studies demonstrated remarkably consistent abnormalities of motor unit morphology on voluntary effort. Apart from the patient who developed a necrotizing myopathy while in the ICU, all patients had high firing motor units with longduration polyphasia in at least two of four muscles sampled. This is indicative of severe chronic partial denervation and was more frequently present in the distal limb muscles. These findings are similar to those of Hund et al. (17) , who found EMG evidence of chronic partial denervation in three patients studied 1.5-3.5 yrs after a diagnosis of critical illness neuropathy, and Berek et al. (13) , who found the same chronic neurogenic EMG changes and similar motor and sensory deficits in 15 CIP patients at 2-3 months after discharge. Zifko (21) also found that neurophysiologic abnormalities persisted up to 2 yrs later. We have shown that such findings may still be present up to 5 yrs after ICU discharge. Some of these patients may also have developed a myopathy during their ICU stay and subsequently recovered, but interestingly, the only patient in whom there was no evidence of chronic partial denervation had a necrotizing myopathy demonstrated histopathologically while in the ICU. Similarly, de Seze et al. (18) and Leitjen et al. (2) found no evidence of myopathy in their patients.
As in other studies (2, 18) , the sensory findings were more variable and are more difficult to explain. The sensory deficits may have been preexistent, may have resulted from surgery or invasive procedures performed in the ICU, from entrapment neuropathy at edematous areas such as the lateral cutaneous nerve of thigh and sural nerve, or could have been a consequence of CIP. Sensory involvement does occur in CIP but is less frequently recognized than motor dysfunction, and any reduction in sensory action potentials is generally less marked than the fall in compound motor action potentials (9, 29) .
Although Schwarz et al. (22) measured jitter in critically ill patients in the ICU, there are no previously published results of this investigation in long-term survivors of intensive care. Fiber density and thermal thresholds have not previously been reported in critically ill patients. The two patients who had common peroneal palsy exhibited increased jitter, and seven of ten patients who had single-fiber electromyography performed had abnormally high values for fiber density in the lower limb muscles. Increased fiber density persists after reinnervation of muscle in both animals and humans and is consistent with the EMG findings (30, 31) . In the thermal threshold tests, four patients had abnormal responses to warming and two to cooling in the foot. The significance of this finding is not clear, although it is in agreement with previous studies in CIP patients attending follow-up (2) .
As more patients survive prolonged critical illness, it is important that hospital clinicians, general practitioners, and those involved in rehabilitation, including nurses and physiotherapists, are aware of the frequency and severity of residual neuromuscular weakness and understand its causes, clinical manifestations, and neurophysiologic features. Follow-up EMG and fiber density determination are a sensitive measure of denervation in survivors of critical illness and can confirm the suspicion of CIP up to several years after discharge. Survivors and their relatives can be counseled that although intensive rehabilitation may be needed in the medium term, the longterm prognosis for functional recovery is usually good. 
